The natural history of Niemann-Pick disease type C in the UK

Journal of Inherited Metabolic Disease

Volumn 30, Issue 1, 2007, Pages 51-59

  Imrie, Jackie ^a   Dasgupta, S ^a   Besley, G T N ^a   Harris, C ^a   Heptinstall, L ^a   Knight, S ^a   Vanier, M T ^b,c   Fensom, A H ^d   Ward, C ^d   Jacklin, E ^a   Whitehouse, C ^a   Wraith, J E ^a  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b INSERM   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MIGLUSTAT; PROTEIN NPC1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CLINICAL FEATURE; COMORBIDITY; DEGENERATIVE DISEASE; DISEASE COURSE; FEMALE; FETUS HYDROPS; FOLLOW UP; GENE MUTATION; HUMAN; LIPIDOSIS; LIVER DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NIEMANN PICK DISEASE; ONSET AGE; PHENOTYPE; PRENATAL PERIOD; UNITED KINGDOM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; LIPID METABOLISM DISORDERS; LIPIDS; MALE; MIDDLE AGED; MODELS, GENETIC; NIEMANN-PICK DISEASE, TYPE C;

EID: 33846412228     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-006-0384-7     Document Type: Article

References (23)

1. Butler JD, Blanchette-Mackie J, Goldin E, et al (1992) Progesterone blocks cholesterol translocation from lysosomes. J Biol Chem 267: 2797-2805.
2. Carstea ED, Morris JA, Coleman KG, et al (1997) Niemann-Pick disease: homology to mediators of cholesterol homeostasis. Science 277: 228-231.
3. Cox TM, Aerts JM, Andria G, et al (2003) The role of iminosugar N -butydeoxynojimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement. J Inherit Metab Dis 26: 513-526.
4. Elstein D, Hollac C, Aerts JM, et al (2004) Sustained therapeutic effects of oral miglustat (Zavesca, N -butyledeoxynojrimycin, OGT 918) in type I Gaucher disease. J Inherit Metab Dis 27: 757-766.
5. Erickson RP, Garver WS, Camargo F, Hossain GS, Heindenreich RA (2000) Pharmacological and genetic modifications of somatic cholesterol do not substantially alter the course of CNS disease in Niemann-Pick C mice. J Inherit Metab Dis 23: 54-62.
6. Grau AJ, Weisbrod M, Niethammer R, et al (1997) Niemann-Pick disease Type C mimicking features of multiple sclerosis. J Neurol/Neurosurg Psych 63: 552.
7. Griffin LD, Gong W, Verot L, Mellon SH (2004) Niemann-Pick type C involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med 10: 704-711.
8. Hsu YS, Hwu WL, Huang SF, et al (1999) Niemann-Pick C disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 24: 103-107.
9. Imrie J, Vijayaraghaven S, Whitehouse C, et al (2002) Niemann-Pick disease type C in adults. J Inherit Metab Dis 25: 491-500.
10. Kaminski WE, Kluemann, HH, Ibach B et al (2002) Identification of novel mutations in the NPC 1 gene in German patients with Niemann-Pick disease. J Inherit Metab Dis 25: 385-389.
11. Kelly DA, Portmann B, Mowat AP, et al (1994) Niemann-Pick disease type C: Diagnosis and outcome in children, with particular reference to liver disease. J Pediatr 124: 665-666.
12. Lachmann RH, te Vruchte D, Lloyd-Evans D, et al (2004) Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C. Neurobiol Dis 16: 654-658.
13. Mieli-Vergani G, Howard ER, Mowat AP (1991) Liver disease in infancy: A 20 year perspective. Gut Suppl S121-128.
14. Millat G, Marcais C, Rafi MA, et al (1999) Niemann-Pick C1 disease: The I1061T substitution is a frequent mutant allele in patients of Western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet 65: 1321-1329.
15. Patterson MC, Di Bisceglie AM, Higgins, et al (1993) The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology 43: 61-64.
16. Patterson MC, Vanier MT, Suzuki K, et al (2001) Niemann-Pick disease type C: A lipid trafficking disorder. In: Scriver CR, Beaudetal Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3611-3633.
17. Patterson M, Vecchio D, Prady H, Ait-Aussa N, Abel L, Wraith E (2005) Oral miglustat in adult and pediatric patients with Niemann-Pick type C (NPC) disease: Rationale, methodology and interim analyses of a clinical study. American Society for Human Genetics, Salt Lake City, October 2005 [Poster].
18. Pentchev PG, Comly ME, Kruth HS, et al (1985) A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci USA 82: 8247-8251.
19. Steinberg SJ, Ward CP, Fensom AH (1994) Complementation studies in Niemann-Pick disease type C indicate the existence of a second group. Med Genet 31: 317-320.
20. Trendleburg G, Vanier MT, Maza S, et al (2006) Niemann-Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry 77: 997-998.
21. Vanier MT, Millat G (2003) Niemann-Pick disease type C. Clin Genet 64: 269-281.
22. Vanier MT, Millat G (2004) Structure and function of the NPC2 protein. Biochim Biophys Acta 1685: 14-21.
23. Vanier MT, Rodriguez-Lafrasse C, Rousson R, et al (1991) Type C Niemann-Pick disease: Spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta 1096: 1328.